Related references
Note: Only part of the references are listed.Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin
Bernard Krust et al.
BIOCHIMIE (2011)
Nucleolin as cell surface receptor for tumor necrosis factor-alpha inducing protein: a carcinogenic factor of Helicobacter pylori
Tatsuro Watanabe et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Nucleolin Is Required for DNA Methylation State and the Expression of rRNA Gene Variants in Arabidopsis thaliana
Frederic Pontvianne et al.
PLOS GENETICS (2010)
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Paula J. Bates et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Nucleolin protein expression in cutaneous melanocytic lesions
Vasileios Mourmouras et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2009)
Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
Sridharan Soundararajan et al.
MOLECULAR PHARMACOLOGY (2009)
IN VITRO CHARACTERIZATION OF A TARGETED, DYE-LOADED NANODEVICE FOR INTRAOPERATIVE TUMOR DELINEATION
Daniel A. Orringer et al.
NEUROSURGERY (2009)
Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression
Patricia Goldhoff et al.
CLINICAL CANCER RESEARCH (2008)
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma
Lee Ridley et al.
NEURO-ONCOLOGY (2008)
Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin
Damien Destouches et al.
PLOS ONE (2008)
Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin
Hubing Shi et al.
BLOOD (2007)
Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication
Iva Ugrinova et al.
BMC MOLECULAR BIOLOGY (2007)
Nucleolin regulates gene expression in CD34-positive hematopoietic cells
Edgar Grinstein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo
Lihua Yang et al.
CANCER RESEARCH (2007)
Vascular targeted nanoparticles for imaging and treatment of brain tumors
G. Ramachandra Reddy et al.
CLINICAL CANCER RESEARCH (2006)
Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization
A. Saxena et al.
ONCOGENE (2006)
Cell cycle-controlled interaction of nucleolin with the retinoblastoma protein and cancerous cell transformation
Edgar Grinstein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A statistical method for comparing viral growth curves
Gary P. Wang et al.
JOURNAL OF VIROLOGICAL METHODS (2006)
Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin
M Takagi et al.
CELL (2005)
Real-time imaging of ligand-induced IKK activation in intact cells and in living mice
S Gross et al.
NATURE METHODS (2005)
Nucleolin interacts with telomerase
S Khurts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
JB Rubin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Traumatic brain injury induced cell proliferation in the adult mammalian central nervous system
S Chirumamilla et al.
JOURNAL OF NEUROTRAUMA (2002)
Share Paper
